PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
PVLA
115 hedge funds and large institutions have $232M invested in Palvella Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 54 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+25
Holders Change %
+27.78%
% of All Funds
2.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
36
Increased
54
Reduced
11
Closed
9
Calls
$244K
Puts
$973K
Net Calls
-$729K
Net Calls Change
-$600K
Top Buyers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$9.17M |
| 2 |
Millennium Management
New York
|
+$7.67M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$6.61M |
| 4 |
Renaissance Technologies
New York
|
+$6M |
| 5 |
Morgan Stanley
New York
|
+$5.01M |
